SRRT and cancer: It has recently been reported that Ars2 is selectively expressed in proliferating cells, particularly in cancer cells, suggesting that Ars2 may be considered as a diagnostic and prognostic marker and a potential target for therapeutic intervention in various diseases, particularly in cancer.